OBJECTIVE: The aim of this study was to study the effect of continued Lactobacillus rhamnosus GG strain (LGG) feeding on rotavirus gastroenteritis in the gnotobiotic (Gn) pig model of virulent human rotavirus (HRV) infection. METHODS: Gn pigs were assigned to treatment groups: mock control, LGG only, HRV only, or LGG plus HRV. Nine days before HRV inoculation (3 days of age), pigs were fed LGG with a daily dose increase of 10-fold from 10³ to 10¹² colony-forming units (CFU). The 10¹² CFU/dose of LGG feeding continued until post-HRV inoculation day (PID) 6. Clinical sign (diarrhea), rotavirus fecal shedding, histopathology of the ileum, adherent junction and tight junction protein expression in the ileal epithelial cells, mucin production in the large and small intestinal contents, and serum cytokine responses from PID 2 to 6 were examined and compared among the treatment groups. RESULTS: Clinically, the percentage of pigs developing diarrhea, the mean duration of diarrhea, and the mean cumulative fecal scores were lower in the LGG fed pigs compared to the nonfed pigs after HRV inoculation. LGG partially protected ileal epithelium against HRV-induced compensatory increases of the adherent junction protein α-catenin and β-catenin, tight junction protein occludin, claudin-3 and claudin-4, and leak protein claudin-2. LGG promoted mucin production because the mucin levels in the large intestinal contents of the LGG+HRV pigs were significantly higher than the HRV-only pigs on PID 2. Additionally, LGG maintained the anti-inflammatory cytokine transforming growth factor-β level in serum after HRV infection. CONCLUSIONS: LGG is moderately effective for ameliorating rotavirus diarrhea by partially preventing injuries to the epithelium.
OBJECTIVE: The aim of this study was to study the effect of continued Lactobacillus rhamnosus GG strain (LGG) feeding on rotavirus gastroenteritis in the gnotobiotic (Gn) pig model of virulent human rotavirus (HRV) infection. METHODS: Gn pigs were assigned to treatment groups: mock control, LGG only, HRV only, or LGG plus HRV. Nine days before HRV inoculation (3 days of age), pigs were fed LGG with a daily dose increase of 10-fold from 10³ to 10¹² colony-forming units (CFU). The 10¹² CFU/dose of LGG feeding continued until post-HRV inoculation day (PID) 6. Clinical sign (diarrhea), rotavirus fecal shedding, histopathology of the ileum, adherent junction and tight junction protein expression in the ileal epithelial cells, mucin production in the large and small intestinal contents, and serum cytokine responses from PID 2 to 6 were examined and compared among the treatment groups. RESULTS: Clinically, the percentage of pigs developing diarrhea, the mean duration of diarrhea, and the mean cumulative fecal scores were lower in the LGG fed pigs compared to the nonfed pigs after HRV inoculation. LGG partially protected ileal epithelium against HRV-induced compensatory increases of the adherent junction protein α-catenin and β-catenin, tight junction protein occludin, claudin-3 and claudin-4, and leak protein claudin-2. LGG promoted mucin production because the mucin levels in the large intestinal contents of the LGG+HRVpigs were significantly higher than the HRV-only pigs on PID 2. Additionally, LGG maintained the anti-inflammatory cytokine transforming growth factor-β level in serum after HRV infection. CONCLUSIONS:LGG is moderately effective for ameliorating rotavirus diarrhea by partially preventing injuries to the epithelium.
Authors: S Guandalini; L Pensabene; M A Zikri; J A Dias; L G Casali; H Hoekstra; S Kolacek; K Massar; D Micetic-Turk; A Papadopoulou; J S de Sousa; B Sandhu; H Szajewska; Z Weizman Journal: J Pediatr Gastroenterol Nutr Date: 2000-01 Impact factor: 2.839
Authors: Vibeke Rosenfeldt; Kim Fleischer Michaelsen; Mogens Jakobsen; Charlotte Nexmann Larsen; Peter Lange Møller; Pernille Pedersen; Michael Tvede; Heike Weyrehter; Niels Henrik Valerius; Anders Paerregaard Journal: Pediatr Infect Dis J Date: 2002-05 Impact factor: 2.129
Authors: Vance J McCracken; Taehoon Chun; Manuel E Baldeón; Siv Ahrné; Göran Molin; Roderick I Mackie; H Rex Gaskins Journal: Exp Biol Med (Maywood) Date: 2002-09
Authors: Shani Ben-Lulu; Yulia Pollak; Jorge Mogilner; Jacob Bejar; Arnold G Coran; Igor Sukhotnik Journal: PLoS One Date: 2012-09-12 Impact factor: 3.240
Authors: Neerja Hajela; B S Ramakrishna; G Balakrish Nair; Philip Abraham; Sarath Gopalan; Nirmal K Ganguly Journal: Indian J Gastroenterol Date: 2015-04-29
Authors: Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes Journal: Nat Rev Dis Primers Date: 2017-11-09 Impact factor: 52.329
Authors: Anastasia N Vlasova; Sukumar Kandasamy; Kuldeep S Chattha; Gireesh Rajashekara; Linda J Saif Journal: Vet Immunol Immunopathol Date: 2016-01-14 Impact factor: 2.046
Authors: M Rigo-Adrover; S Saldaña-Ruíz; K van Limpt; K Knipping; J Garssen; J Knol; A Franch; M Castell; F J Pérez-Cano Journal: Eur J Nutr Date: 2016-04-25 Impact factor: 5.614